Andrew L. Taylor

Chief Financial OfficeratOrchestra BioMed Holdings· In proxies 2022–2025

Pay in FY2025+14% from the year before · Orchestra BioMed Holdings stock +3.8% the same year

Andrew L. Taylor was paid $1.2M in FY2025 (Dec), up 14%. Orchestra BioMed Holdings stock rose 3.8% that year.

Pay$100 in the stock at the end of FY21 → $41

Pay is from the Summary Compensation Table of each Orchestra BioMed Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

OBIO
Orchestra BioMed HoldingsPublic company · 4 yr
- Chief Financial Officer2022 – Present · 4 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

Pay
Orchestra BioMed Holdings CFO pay rose 14% to $1.2M. The stock rose 4% in FY2025 (Dec).
DEF 14AApr 29, 2026
Pay
Orchestra BioMed Holdings CFO pay fell 56% to $1.1M. The stock fell 56% in FY2024 (Dec).
DEF 14AApr 30, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?